ARHS

Petco Health & Wellness (WOOF) and Arhaus, Inc. (ARHS) are both Retail - Miscellaneous sector stocks with Zacks Rank #1 (Strong Buy) ratings. However, WOOF presents a better value opportunity with a forward P/E of 9.33 compared to ARHS's 18.18, a PEG ratio of 0.85 versus 3.08, and a P/B ratio of 0.6 versus 3.33. WOOF earned a Value grade of A while ARHS received a C grade.

Arhaus, Inc. (ARHS) is highlighted as an attractive investment opportunity combining fast-paced momentum with bargain valuation. The stock has gained 22.8% over four weeks and 24.4% over 12 weeks, with a high beta of 2.29 indicating significant price volatility. Despite strong momentum metrics and a Zacks Rank #1 (Strong Buy) rating driven by upward earnings estimate revisions, ARHS trades at a reasonable valuation with a Price-to-Sales ratio of 0.98, suggesting significant upside potential.

Zacks Premium offers investment research tools including the Zacks Rank and Style Scores to help investors identify high-performing stocks. The platform highlights Arhaus, Inc. (ARHS) as a stock to watch with a #3 Hold rank and VGM Score of A, noting strong momentum with shares up 13.2% over four weeks and upward earnings revisions.

Arhaus, Inc. (ARHS) is highlighted as a potential growth investment with a #3 (Hold) Zacks Rank and B-rated VGM and Growth Style Scores. The premium home furnishings company is forecasted to achieve 12.5% year-over-year earnings growth for the current fiscal year, with eight analysts revising earnings estimates upward in the last 60 days. The article emphasizes using Zacks Style Scores alongside the Zacks Rank to identify stocks with the best potential for outperformance.

Bath & Body Works shares surged 8.7% to close at $17.46 on solid volume, despite a 17.7% loss over the past four weeks. The company is expected to report quarterly earnings of $0.11 per share (down 68.6% year-over-year) with revenues of $1.54 billion (down 3.4%).

However, a positive 0.9% upward revision in EPS estimates over the last 30 days suggests potential near-term strength. The stock carries a Zacks Rank #3 (Hold) rating.